Øivind Torkildsen

5.0k total citations
126 papers, 3.3k citations indexed

About

Øivind Torkildsen is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Øivind Torkildsen has authored 126 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pathology and Forensic Medicine, 33 papers in Immunology and 27 papers in Oncology. Recurrent topics in Øivind Torkildsen's work include Multiple Sclerosis Research Studies (83 papers), Polyomavirus and related diseases (21 papers) and Peripheral Neuropathies and Disorders (17 papers). Øivind Torkildsen is often cited by papers focused on Multiple Sclerosis Research Studies (83 papers), Polyomavirus and related diseases (21 papers) and Peripheral Neuropathies and Disorders (17 papers). Øivind Torkildsen collaborates with scholars based in Norway, United States and Netherlands. Øivind Torkildsen's co-authors include Kjell‐Morten Myhr, Lars Bø, Stig Wergeland, Trygve Holmøy, K-M Myhr, Linn Anne Brunborg, Christian A. Vedeler, Rune Midgard, Nina Grytten and Kristin N. Varhaug and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Øivind Torkildsen

119 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Øivind Torkildsen Norway 31 1.9k 797 714 521 472 126 3.3k
Marcus Koch Canada 36 2.2k 1.2× 444 0.6× 668 0.9× 891 1.7× 336 0.7× 117 4.1k
Fabrizio Giuliani Canada 29 1.4k 0.7× 1.2k 1.6× 1.1k 1.6× 667 1.3× 442 0.9× 69 4.6k
Stefan Bittner Germany 39 1.7k 0.9× 1.0k 1.3× 1.5k 2.1× 797 1.5× 582 1.2× 201 4.9k
Jennifer Graves United States 31 1.8k 0.9× 403 0.5× 970 1.4× 714 1.4× 272 0.6× 119 3.4k
Kjetil Bjørnevik United States 22 1.3k 0.7× 550 0.7× 497 0.7× 627 1.2× 471 1.0× 62 2.7k
Joost Smolders Netherlands 33 2.5k 1.3× 1.9k 2.3× 505 0.7× 300 0.6× 361 0.8× 103 4.1k
Raymond Hupperts Netherlands 40 3.1k 1.6× 1.9k 2.3× 635 0.9× 623 1.2× 439 0.9× 124 4.9k
Magnus Andersson Sweden 32 1.3k 0.7× 641 0.8× 583 0.8× 508 1.0× 386 0.8× 65 3.0k
Trygve Holmøy Norway 36 2.3k 1.2× 1.2k 1.5× 515 0.7× 788 1.5× 470 1.0× 170 3.8k
Zsolt Illés Hungary 38 1.8k 1.0× 2.1k 2.7× 968 1.4× 1.4k 2.7× 594 1.3× 217 5.4k

Countries citing papers authored by Øivind Torkildsen

Since Specialization
Citations

This map shows the geographic impact of Øivind Torkildsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øivind Torkildsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øivind Torkildsen more than expected).

Fields of papers citing papers by Øivind Torkildsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øivind Torkildsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øivind Torkildsen. The network helps show where Øivind Torkildsen may publish in the future.

Co-authorship network of co-authors of Øivind Torkildsen

This figure shows the co-authorship network connecting the top 25 collaborators of Øivind Torkildsen. A scholar is included among the top collaborators of Øivind Torkildsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Øivind Torkildsen. Øivind Torkildsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torkildsen, Øivind, et al.. (2025). Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate. Neurology Neuroimmunology & Neuroinflammation. 13(1). e200522–e200522.
2.
Høgestøl, Einar August, Øivind Torkildsen, Kjetil Bjørnevik, et al.. (2025). Comparative effectiveness of rituximab and cladribine in relapsing–remitting multiple sclerosis: A target trial emulation. Multiple Sclerosis Journal. 31(8). 975–984.
3.
Otero‐Ortega, Laura, et al.. (2025). In-Depth Characterization of L1CAM+ Extracellular Vesicles as Potential Biomarkers for Anti-CD20 Therapy Response in Relapsing–Remitting Multiple Sclerosis. International Journal of Molecular Sciences. 26(15). 7213–7213. 1 indexed citations
4.
Wessels, M., Jop Mostert, Bob W. van Oosten, et al.. (2024). The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis. Multiple Sclerosis and Related Disorders. 91. 105900–105900. 1 indexed citations
5.
Torkildsen, Øivind, Jan Aarseth, Marianna Cortese, et al.. (2024). Migraine in the multiple sclerosis prodrome: a prospective nationwide cohort study in pregnant women. The Journal of Headache and Pain. 25(1). 225–225. 1 indexed citations
6.
Torkildsen, Øivind, et al.. (2022). Safety of breast feeding during rituximab treatment in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 94(1). 38–41. 14 indexed citations
7.
Torkildsen, Øivind, Jan Aarseth, Elisabeth Gulowsen Celius, et al.. (2022). Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy. Journal of Neurology. 269(11). 5901–5909. 3 indexed citations
8.
Wesnes, Kristin, Kjell‐Morten Myhr, Trond Riise, et al.. (2021). Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. Multiple Sclerosis and Related Disorders. 50. 102801–102801. 15 indexed citations
9.
Torkildsen, Øivind, Jan Aarseth, Heidi Øyen Flemmen, et al.. (2021). Perinatal Depression and Anxiety in Women With Multiple Sclerosis. Neurology. 96(23). e2789–e2800. 22 indexed citations
10.
Røsjø, Egil, Jonas Christoffer Lindstrøm, Trygve Holmøy, et al.. (2020). Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis. Frontiers in Neurology. 11. 329–329. 12 indexed citations
11.
Røsjø, Egil, Andreas Lossius, Nada Abdelmagid, et al.. (2016). Effect of high-dose vitamin D 3 supplementation on antibody responses against Epstein–Barr virus in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 23(3). 395–402. 46 indexed citations
12.
Kvistad, Christopher Elnan, et al.. (2016). Trombolytisk behandling og trombektomi ved ukjent slagdebut. Tidsskrift for Den norske legeforening. 136(16). 1363–1363. 1 indexed citations
13.
Torkildsen, Øivind, et al.. (2016). Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis. BMJ Case Reports. 2016. bcr2016214555–bcr2016214555. 5 indexed citations
14.
Røsjø, Egil, Kjell‐Morten Myhr, Kristin I. Løken-Amsrud, et al.. (2015). Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 280. 21–28. 14 indexed citations
15.
Myhr, Kjell‐Morten, Trygve Holmøy, Jūratė Šaltytė Benth, et al.. (2015). Body mass index influence interferon-beta treatment response in multiple sclerosis. Journal of Neuroimmunology. 288. 92–97. 50 indexed citations
16.
Holmøy, Trygve, Kristin I. Løken-Amsrud, S. J. Bakke, et al.. (2013). Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity. PLoS ONE. 8(9). e75021–e75021. 29 indexed citations
17.
Løken-Amsrud, Kristin I., Trygve Holmøy, S. J. Bakke, et al.. (2012). Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment. Neurology. 79(3). 267–273. 90 indexed citations
18.
Gavasso, Sonia, et al.. (2012). Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls. Acta Neurologica Scandinavica. 126. 84–89. 2 indexed citations
19.
Torkildsen, Øivind, Stig Wergeland, S. J. Bakke, et al.. (2012). ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study). Archives of Neurology. 69(8). 1044–51. 110 indexed citations
20.
Wergeland, Stig, Øivind Torkildsen, Lars Bø, & Kjell‐Morten Myhr. (2012). Polyunsaturated fatty acids in multiple sclerosis therapy. Acta Neurologica Scandinavica. 126(195). 70–75. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcus Koch Breakdown of academic impact, for papers by Fabrizio Giuliani Breakdown of academic impact, for papers by Stefan Bittner Breakdown of academic impact, for papers by Jennifer Graves Breakdown of academic impact, for papers by Kjetil Bjørnevik Breakdown of academic impact, for papers by Joost Smolders Breakdown of academic impact, for papers by Raymond Hupperts Breakdown of academic impact, for papers by Magnus Andersson Breakdown of academic impact, for papers by Trygve Holmøy Breakdown of academic impact, for papers by Zsolt Illés
Rankless by CCL
2026